chemotherapeutical


Also found in: Thesaurus.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.chemotherapeutical - of or relating to chemotherapy
Mentioned in ?
References in periodicals archive ?
Introduction: Current inventories on quality of life used in oncology record mainly chemotherapeutical effects (EORTC QLQ C30) or the status of rehabilitative function (SF 36).
The combinations of tetrandrine and fangchinoline with a single chemotherapeutical drug doxorubicin were investigated in MDR Caco-2, CEM/ADR5000 cells and in sensitive HCT-116, CEM/CCRF cells.
Diffuse kidney enlargement has numerous causes and its differential diagnosis is difficult Diffuse renal enlargement can be observed in response to chemotherapeutical agents in patients with tumor lysis syndrome secondary to infections or tumor involvement (5).
However, there was no association between this lower value and the total dose of the chemotherapeutical drug.
Chemotherapeutical residues and resistance in post-partum sows during herd treatment [in German].
The combination of these two chemotherapeutical agents did show synergism, a greater effect.
Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at -20[degrees]C.
How the mind handles these chemotherapeutical assaults and what the spirit makes of the cancer that defeats them fall into a great silence.
LOS ANGELES -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that the Data Safety Monitoring Committee overseeing the Company's global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) has recommended conducting the clinical trial through completion.
Combining P-gp inhibitors with chemotherapeutical agents might be a strategy to counteract MDR in cancer cells (Wink et al.
LOS ANGELES -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced the recommendation by the Data Safety Monitoring Board (DSMB) to continue with the global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC).
harmine, and sanguinarine), phenolics (EGCG and thymol), and terpenoids (menthol, aromadendrene, 13-sitosterol-0-glucoside, and I3-carotene), alone or in combination with the saponin digitonin to reverse the relative multi-drug resistance of Caco-2 and CEM/ADR5000 cells to the chemotherapeutical agent doxorubicin.